中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月8日星期二
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2022, Vol. 29 Issue (31): 185-188    
  中西医结合研究 本期目录 | 过刊浏览 | 高级检索 |
中医益血汤联合粒细胞集落刺激因子对乳腺癌术后化疗患者血象、免疫功能及预后的影响
赖圆瑾
南昌市第三医院中医科,江西南昌 330008
Effect of Traditional Chinese Medicine Yixue Decoction combined with granulocyte colony stimulating factor on hemogram,immune function and prognosis of patients with breast cancer after chemotherapy
LAI Yuanjin
Department of Traditional Chinese Medicine,the Third Hospital of Nanchang,Jiangxi Province,Nanchang 330008,China
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨中医益血汤联合粒细胞集落刺激因子(G-CSF)对乳腺癌术后化疗患者血象、免疫功能及预后的影响。方法 选择2017 年11 月至2020 年6 月南昌市第三医院收治的70 例乳腺癌术后化疗患者作为研究对象,采用随机数字表法分为观察组和对照组,各35 例。对照组于化疗结束后采用G-CSF 治疗,观察组于对照组基础上采用中医益血汤治疗。比较两组患者血象指标[白细胞(WBC)、血小板(PLT)、血红蛋白(Hb)]、免疫功能[CD3+、CD4+、CD8+、CD4+/CD8+]、乳腺癌患者生命质量测定量表(FACT-B)(情感、生理、功能、家庭/社会状况、附加关注)、随访1 年复发率及生存率。结果 治疗后,两组患者PLT 水平低于本组治疗前,且观察组PLT 水平低于对照组,差异有统计学意义(P<0.05);两组患者WBC、Hb 水平高于本组治疗前,且观察组WBC、Hb 水平高于对照组,差异有统计学意义(P<0.05)。治疗后,两组患者CD8+水平低于本组治疗前,且观察组CD8+水平低于对照组,差异有统计学意义(P<0.05);两组患者CD3+、CD4+、CD4+/CD8+水平高于本组治疗前,且观察组CD3+、CD4+、CD4+/CD8+水平高于对照组,差异有统计学意义(P<0.05)。治疗后,两组患者情感、生理、功能、家庭/社会状况、附加关注评分高于本组治疗前,且观察组高于对照组,差异有统计学意义(P<0.05)。观察组复发率低于对照组,生存率高于对照组,差异有统计学意义(P<0.05)。结论 中医益血汤联合G-CSF 治疗乳腺癌术后化疗患者,可改善血象、免疫功能,获得较好的预后,临床应当关注。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
赖圆瑾
关键词 中医益血汤粒细胞集落刺激因子乳腺癌化疗    
Abstract:Objective To explore the effect of TCM Yixue Decoction combined with granulocyte colony stimulating factor(G-CSF)on hemogram,immune function and prognosis of patients with breast cancer after chemotherapy.Methods A total of 70 patients with postoperative chemotherapy of breast cancer admitted to the Third Hospital of Nanchang from November 2017 to June 2020 were selected as the research objects.They were divided into observation group and control group according to the random number table method,with 35 cases in each group.The control group was treated with G-CSF after chemotherapy,while the observation group was treated with TCM Yixue Decoction on the basis of the control group.The blood picture indexes (white blood cell [WBC],platelet [PLT],hemoglobin [Hb]),immune function (CD3+,CD4+,CD8+,CD4+/CD8+),breast cancer patients' quality of life scale (FACT-B) (emotion,physiology,function,family/social status,additional attention) were compared between the two groups.Results After treatment,the PLT level of patients of the two group was lower than that of before treatment,and the PLT level of the observation group was lower than that of the control group,and the difference was statistically significant (P<0.05).The WBC and Hb levels of patients of the two group were higher than thosse before treatment,and WBC and Hb levels of the observation group were higher than those of the control group,and the differences were statistically significant (P<0.05).After treatment,the CD8+levels of patients of the two group were lower than those before treatment,and the CD8+level of the observation group was lower than that of the control group,and the difference was statistically significant (P<0.05).The CD3+,CD4+,CD4+/CD8+levels of patients of the two group were higher than those before treatment,and CD3+,CD4+,CD4+/CD8+levels of the observation group were higher than those of the control group,and the differences were statistically significant (P<0.05).After treatment,the emotional,physical,functional,family/social status,and additional concern scores of patients of the two group were higher than those before treatment,and emotional,physical,functional,family/social status,and additional concern scores of the observation group were higher than those of the control group,and the differences were statistically significant (P<0.05).The relapse rate in the observation group was lower than that in the control group,and the survival rate was higher than that in the control group,with statistically significant differences (P<0.05).Conclusion Traditional Chinese Medicine Yixue Decoction combined with G-CSF can improve the hemogram and immune function of patients with breast cancer after chemotherapy,and obtain better prognosis,which should be paid attention to clinically.
Key wordsTraditional Chinese Medicine Yixue Decoction    Granulocyte colony stimulating factor    Breast cancer    Chemotherapy
    
基金资助:江西省卫生健康委科技计划项目(202211552)
作者简介: 赖圆瑾(1989-),女,汉族,硕士,研究方向:中医内科学。
引用本文:   
赖圆瑾. 中医益血汤联合粒细胞集落刺激因子对乳腺癌术后化疗患者血象、免疫功能及预后的影响[J]. 中国当代医药, 2022, 29(31): 185-188.
LAI Yuanjin. Effect of Traditional Chinese Medicine Yixue Decoction combined with granulocyte colony stimulating factor on hemogram,immune function and prognosis of patients with breast cancer after chemotherapy. 中国当代医药, 2022, 29(31): 185-188.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2022/V29/I31/185
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载